29th Annual Meeting of the European Bone and Joint Infection Society

Thursday, September 2, 2010, 01:30 – 02:45 pm

Room: Gustav-Mahler-Zimmer

All workshops are free of charge for participants.

WS 1	aap Implantate AG Vorsitz: C. Wagner (Ludwigshafen, Germany) Osteomycin – Antibiotic impregnated bone allograft Karl-Heinz Kaudela, MD, Medical Director Orthopedic and trauma surgeon ECTB – European Cell and Tissue Bank / Vienna, Austria Jason® G – The new generation of Gentamicin collagen fleeces Lydia Heimann, PhD, Projektmanager F&E aap Biomaterials GmbH / Obernburg, Germany PerOssal – Efficient bone defect treatment even with infections Theodoros Pavlidis, MD, Assistant Medical Director Universitätsklinikum Gießen und Marburg (UKGM) Klinik und Poliklinik für Unfallchirurgie / Gießen, Germany

WS 1

aap Implantate AG
Vorsitz: C. Wagner (Ludwigshafen, Germany)

Osteomycin – Antibiotic impregnated bone allograft
Karl-Heinz Kaudela, MD, Medical Director
Orthopedic and trauma surgeon
ECTB – European Cell and Tissue Bank / Vienna, Austria
Jason® G – The new generation of Gentamicin collagen fleeces
Lydia Heimann, PhD, Projektmanager F&E
aap Biomaterials GmbH / Obernburg, Germany
PerOssal – Efficient bone defect treatment even with infections
Theodoros Pavlidis, MD, Assistant Medical Director
Universitätsklinikum Gießen und Marburg (UKGM)
Klinik und Poliklinik für Unfallchirurgie / Gießen, Germany

WS 2	Biomet Deutschland GmbH Infection Prevention for Cementless Joint Replacement Vorsitz: V. Heppert (Ludwigshafen, Germany) Scientific background N. Düwelhenkel (Berlin, Germany) Economic aspects V. Alt (Gießen, Germany) Clinical relevance D. Stengel (Berlin, Germany) Discussion